Investing Profile

Daniel Estes

InvestorVC
General Partner at Frazier Healthcare Partners
Photo of Daniel Estes, General Partner at Frazier Healthcare Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $5.0M
$1.5M
13
CompanyStageDateRound SizeTotal Raised
Sidewinder Therapeutics
Series BApr 2026$140M
$140M
Co-investors: John Hamer (DCVC (Data Collective)), Michal Silverberg (Novartis Venture Fund)
Iolyx Therapeutics
Series BDec 2025$15M
$15M
Hillstar Bio
Series AMar 2025$67M
$67M
Callio Therapeutics
Series AMar 2025$190M
$190M
Alesta Therapeutics
Series AJan 2025$67M
$67M
Co-investors: Laura Brass (MPM BioImpact)
Bluejay Therapeutics
Series CMay 2024$180M
$220M
Co-investors: Nancy Hong (San Diego Symphony)
Sudo Biosciences
Series BFeb 2024$30M
Series BDec 2023$120M
Series ASep 2022$37M
$180M
Co-investors: Shinichiro Fuse
Radionetics Oncology
SeedOct 2021$30M
$30M